2023 annual financial data
InMed Pharmaceuticals 2023 Net income growth
Direct answer
Net income growth was 57.27%.
Operating income was -8,378,787 CAD and net income was -7,947,622 CAD.
Operating cash flow was -7,283,199 CAD.
Get free InMed Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,135,561 CAD
- Operating income
- -8,378,787 CAD
- Net income
- -7,947,622 CAD
- Operating cash flow
- -7,283,199 CAD